Is the vitamin‑A dosing schedule for measles you described based on current clinical guidelines (e.g., WHO, CDC)?

Yes, the vitamin A dosing schedule for measles is directly based on current clinical guidelines from WHO, CDC, and AAP.

The vitamin A supplementation protocol for measles treatment is explicitly recommended by the World Health Organization, Centers for Disease Control and Prevention, and American Academy of Pediatrics, with specific dosing schedules published in official guideline documents. 1, 2, 3

Guideline-Based Dosing Protocol

Standard Two-Dose Regimen for Complicated Measles

• Children ≥12 months and adults: 200,000 IU orally on day 1, followed by 200,000 IU on day 2 1, 3
• Children <12 months: 100,000 IU orally on day 1, followed by 100,000 IU on day 2 2, 3
• This two-dose protocol is specifically indicated for complicated measles (pneumonia, otitis media, croup, diarrhea with dehydration, or neurological problems) 1, 3

Extended Three-Dose Protocol for Eye Symptoms

• When any eye symptoms of vitamin A deficiency are present (xerosis, Bitot's spots, keratomalacia, or corneal ulceration), the American Academy of Pediatrics recommends a third dose of 200,000 IU administered 1-4 weeks after the initial two doses 1
• For infants <12 months with eye symptoms, the third dose is 100,000 IU 1

Guideline Sources

The dosing recommendations come from:

• World Health Organization official treatment protocols 1, 3
• Centers for Disease Control and Prevention MMWR Recommendations and Reports 1, 3
• American Academy of Pediatrics clinical practice guidelines 1, 2

Evidence Base Supporting Guidelines

• The guideline recommendations are supported by high-quality randomized controlled trials showing a 64% reduction in overall mortality (RR 0.36) and 67% reduction in pneumonia-specific mortality (RR 0.33) with the two-dose regimen 3, 4
• An 82% mortality reduction was demonstrated specifically in children <2 years of age (RR 0.18) 3, 4
• Individual landmark trials from South Africa and Tanzania confirmed these benefits, with one study showing relative risk of death or major complication of 0.51 (95% CI 0.35-0.74) 5, 6

Critical Clinical Context

• The WHO and CDC emphasize that vitamin A supplementation is the only evidence-based intervention proven to reduce measles mortality 2, 3
• These guidelines apply globally, though they were developed with particular attention to areas where vitamin A deficiency may be present 3
• The standard protocol carries no toxicity concerns, as acute toxicity requires >300,000 IU in adults or >60,000 IU in children 1